ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,860 | +46.4% | 14,623 | -9.6% | 0.00% | 0.0% |
| Q2 2023 | $16,986 | +106062.5% | 16,177 | +17.6% | 0.00% | 0.0% |
| Q1 2023 | $16 | -67.3% | 13,751 | -57.9% | 0.00% | -50.0% |
| Q4 2022 | $49 | -99.3% | 32,628 | +1238.3% | 0.00% | – |
| Q3 2022 | $7,000 | -50.0% | 2,438 | -42.3% | 0.00% | – |
| Q2 2022 | $14,000 | -68.2% | 4,227 | -56.0% | 0.00% | – |
| Q1 2022 | $44,000 | +18.9% | 9,613 | +86.9% | 0.00% | -100.0% |
| Q4 2021 | $37,000 | +23.3% | 5,144 | +631.7% | 0.00% | 0.0% |
| Q3 2021 | $30,000 | – | 703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $15,722,025 | 18.03% |
| Alphabet Inc. | 5,680,785 | $9,657,334 | 0.62% |
| 683 Capital Management, LLC | 4,000,000 | $6,800,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $3,293,252 | 0.37% |
| Acuitas Investments, LLC | 208,579 | $354,584 | 0.21% |
| MAVERICK CAPITAL LTD | 5,270,290 | $8,959,493 | 0.20% |
| Orbimed Advisors | 5,270,400 | $8,959,680 | 0.19% |
| Slate Path Capital LP | 3,735,000 | $6,349,500 | 0.18% |
| Redmile Group, LLC | 1,440,725 | $2,449,233 | 0.12% |
| TANG CAPITAL MANAGEMENT LLC | 366,536 | $623,111 | 0.09% |